275 related articles for article (PubMed ID: 8751230)
21. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
Tepes B; Kavcic B; Gubina M; Krizman I
Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
[TBL] [Abstract][Full Text] [Related]
22. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole].
Wilhelmsen I; Hundal O; Berstad K; Berstad A
Tidsskr Nor Laegeforen; 1992 Oct; 112(25):3197-9. PubMed ID: 1462293
[TBL] [Abstract][Full Text] [Related]
24. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
25. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
26. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
27. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
29. Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives.
McMahon BJ; Bruce MG; Hennessy TW; Bruden DL; Sacco F; Peters H; Hurlburt DA; Morris JM; Reasonover AL; Dailide G; Berg DE; Parkinson AJ
Aliment Pharmacol Ther; 2006 Apr; 23(8):1215-23. PubMed ID: 16611283
[TBL] [Abstract][Full Text] [Related]
30. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori reinfection after apparent eradication--the Ipswich experience.
Bell GD; Powell KU
Scand J Gastroenterol Suppl; 1996; 215():96-104. PubMed ID: 8722391
[TBL] [Abstract][Full Text] [Related]
32. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
[TBL] [Abstract][Full Text] [Related]
33. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
[TBL] [Abstract][Full Text] [Related]
34. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
35. Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies.
Kate V; Ananthakrishnan N; Badrinath S
Br J Surg; 2001 Aug; 88(8):1054-8. PubMed ID: 11488789
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States.
Abu-Mahfouz MZ; Prasad VM; Santogade P; Cutler AF
Am J Gastroenterol; 1997 Nov; 92(11):2025-8. PubMed ID: 9362184
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori reinfection in Brazilian patients with peptic ulcer disease: a 5-year follow-up.
Silva FM; Navarro-Rodriguez T; Barbuti RC; Mattar R; Hashimoto CL; Eisig JN
Helicobacter; 2010 Feb; 15(1):46-52. PubMed ID: 20302589
[TBL] [Abstract][Full Text] [Related]
38. [Therapy of Helicobacter pylori infection: current status].
Wagner S; Gebel M; Manns M
Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding.
Gisbert JP; Calvet X; Cosme A; Almela P; Feu F; Bory F; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Benages A; Cañete N; Montoro M; Borda F; Pérez-Aisa A; Piqué JM;
Am J Gastroenterol; 2012 Aug; 107(8):1197-204. PubMed ID: 22613904
[TBL] [Abstract][Full Text] [Related]
40. Spiramycin in triple therapy of Helicobacter pylori-associated peptic ulcer disease. An open pilot study with 12-month follow-up.
Berstad A; Berstad K; Wilhelmsen I; Hatlebakk JG; Nesje LB; Hausken T
Aliment Pharmacol Ther; 1995 Apr; 9(2):197-200. PubMed ID: 7605862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
